Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pro Concepta Zug AG (formerly Pro Diagnostica Trading AG) was a Swiss pharmaceutical company based in Zug, Switzerland, that specialized in the wholesale, import, export, and representation of pharmaceutical, biological, and chemical-technical products. The company held marketing authorizations and distributed several well-known prescription and over-the-counter (OTC) drugs in Switzerland, including the immunosuppressants Imurek (azathioprine) and Puri-Nethol (mercaptopurine), the chemotherapy drug Alkeran (melphalan), and the pain medication Fentanyl. Pro Concepta Zug AG was also the parent company of Pro Farma AG (formerly Pro Farma GmbH), which was acquired by the Italian pharmaceutical group Recordati in July 2016. Pro Concepta Zug AG was officially deleted from the Swiss commercial registry in May 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pro Concepta.